# FDA Inspection 1107981 - Amphastar Nanjing Pharmaceuticals Inc - October 11, 2019

Source: https://www.keypedia.com/records/fda_inspections/amphastar-nanjing-pharmaceuticals-inc/de1ebcb6-0431-47b6-9c53-ff8d6896a271
Source feed: FDA_Inspections

> FDA Inspection 1107981 for Amphastar Nanjing Pharmaceuticals Inc on October 11, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1107981
- Company Name: Amphastar Nanjing Pharmaceuticals Inc
- Inspection Date: 2019-10-11
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1291882 - 2025-09-19](https://www.keypedia.com/records/fda_inspections/amphastar-nanjing-pharmaceuticals-inc/8c11e7e8-9c3d-43fb-940f-6748a59595b1)
- [FDA Inspection 1269036 - 2025-03-07](https://www.keypedia.com/records/fda_inspections/amphastar-nanjing-pharmaceuticals-inc/746ea47e-ddae-4850-b180-89e92ad2aab7)
- [FDA Inspection 1269036 - 2025-03-07](https://www.keypedia.com/records/fda_inspections/amphastar-nanjing-pharmaceuticals-inc/5aaee4a3-8301-4705-b1ed-65d902350f3a)
- [FDA Inspection 1036696 - 2017-10-26](https://www.keypedia.com/records/fda_inspections/amphastar-nanjing-pharmaceuticals-inc/577c698d-0a4f-45ae-8040-b00b8517a31d)
- [FDA Inspection 969870 - 2016-04-29](https://www.keypedia.com/records/fda_inspections/amphastar-nanjing-pharmaceuticals-inc/cdbd97cf-5fb3-4de3-8f49-2dc30897409b)

Company: https://www.keypedia.com/companies/amphastar-nanjing-pharmaceuticals-inc/ad29710e-4137-4608-933e-8292394dcbc7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c